Steady‐state antigen‐expressing dendritic cells terminate CD4+ memory T‐cell responses

M Nasreen, TM Waldie, CM Dixon… - European journal of …, 2010 - Wiley Online Library
M Nasreen, TM Waldie, CM Dixon, RJ Steptoe
European journal of immunology, 2010Wiley Online Library
CD4+ T cells are important effectors of inflammation and tissue destruction in many diseases
of immune dysregulation. As memory T cells develop early during the preclinical stages of
autoimmune and inflammatory diseases, immunotherapeutic approaches to treatment of
these diseases, once established, must include the means to terminate memory T‐cell
responses. Traditionally, it has been considered that, due to their terminally differentiated
nature, memory T cells are resistant to tolerance induction, although emerging evidence …
Abstract
CD4+ T cells are important effectors of inflammation and tissue destruction in many diseases of immune dysregulation. As memory T cells develop early during the preclinical stages of autoimmune and inflammatory diseases, immunotherapeutic approaches to treatment of these diseases, once established, must include the means to terminate memory T‐cell responses. Traditionally, it has been considered that, due to their terminally differentiated nature, memory T cells are resistant to tolerance induction, although emerging evidence indicates that some immunotherapeutic approaches can terminate memory T‐cell responses. Here, we demonstrate that CD4+ memory T‐cell responses can be terminated when cognate antigen is transgenically expressed in steady‐state DC. Transfer of in‐vitro‐generated CD4+ memory T cells establishes, in nontransgenic recipients, a stable and readily recalled memory response to cognate antigen. In contrast, upon transfer to mice expressing cognate antigen targeted to DC, memory CD4+ T cells undergo a phase of limited proliferation followed by substantial deletion, and recall responses are effectively silenced. This finding is important in understanding how to effectively apply immunotherapy to ongoing T‐cell‐mediated autoimmune and inflammatory diseases.
Wiley Online Library